vs
爱齐科技(ALGN)与Cellectis S.A.(CLLS)财务数据对比。点击上方公司名可切换其他公司
爱齐科技的季度营收约是Cellectis S.A.的110.2倍($1.0B vs $9.5M)。爱齐科技净利率更高(13.0% vs -265.9%,领先278.8%)。Cellectis S.A.同比增速更快(375.0% vs 5.3%)。爱齐科技自由现金流更多($187.3M vs $27.6M)
爱齐科技是一家全球知名医疗设备企业,主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务,客户覆盖正畸医师、全科牙医,面向修复、美容牙科领域,业务分为透明矫治器、扫描仪及服务两大板块,可满足青少年等不同群体的正畸需求
Cellectis S.A.是一家法国生物制药公司,专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术,目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构,在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
ALGN vs CLLS — 直观对比
营收规模更大
ALGN
是对方的110.2倍
$9.5M
营收增速更快
CLLS
高出369.7%
5.3%
净利率更高
ALGN
高出278.8%
-265.9%
自由现金流更多
ALGN
多$159.7M
$27.6M
损益表 — Q4 2025 vs Q2 2024
| 指标 | ||
|---|---|---|
| 营收 | $1.0B | $9.5M |
| 净利润 | $135.8M | $-25.3M |
| 毛利率 | 65.3% | — |
| 营业利润率 | 14.8% | -181.1% |
| 净利率 | 13.0% | -265.9% |
| 营收同比 | 5.3% | 375.0% |
| 净利润同比 | 30.8% | -51.9% |
| 每股收益(稀释后) | $1.88 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALGN
CLLS
| Q4 25 | $1.0B | — | ||
| Q3 25 | $995.7M | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $979.3M | — | ||
| Q4 24 | $995.2M | — | ||
| Q3 24 | $977.9M | — | ||
| Q2 24 | $1.0B | $9.5M | ||
| Q1 24 | $997.4M | — |
净利润
ALGN
CLLS
| Q4 25 | $135.8M | — | ||
| Q3 25 | $56.8M | — | ||
| Q2 25 | $124.6M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $103.8M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $96.6M | $-25.3M | ||
| Q1 24 | $105.0M | — |
毛利率
ALGN
CLLS
| Q4 25 | 65.3% | — | ||
| Q3 25 | 64.2% | — | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 69.5% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 69.7% | — | ||
| Q2 24 | 70.3% | — | ||
| Q1 24 | 70.0% | — |
营业利润率
ALGN
CLLS
| Q4 25 | 14.8% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 13.4% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 16.6% | — | ||
| Q2 24 | 14.3% | -181.1% | ||
| Q1 24 | 15.5% | — |
净利率
ALGN
CLLS
| Q4 25 | 13.0% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 9.5% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 11.9% | — | ||
| Q2 24 | 9.4% | -265.9% | ||
| Q1 24 | 10.5% | — |
每股收益(稀释后)
ALGN
CLLS
| Q4 25 | $1.88 | — | ||
| Q3 25 | $0.78 | — | ||
| Q2 25 | $1.72 | — | ||
| Q1 25 | $1.27 | — | ||
| Q4 24 | $1.40 | — | ||
| Q3 24 | $1.55 | — | ||
| Q2 24 | $1.28 | $-0.28 | ||
| Q1 24 | $1.39 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $149.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.0B | $148.6M |
| 总资产 | $6.2B | $407.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ALGN
CLLS
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $901.2M | — | ||
| Q1 25 | $873.0M | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $761.4M | $149.0M | ||
| Q1 24 | $865.8M | — |
股东权益
ALGN
CLLS
| Q4 25 | $4.0B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $3.9B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.8B | $148.6M | ||
| Q1 24 | $3.8B | — |
总资产
ALGN
CLLS
| Q4 25 | $6.2B | — | ||
| Q3 25 | $6.2B | — | ||
| Q2 25 | $6.2B | — | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.2B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.2B | $407.1M | ||
| Q1 24 | $6.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $223.2M | $28.9M |
| 自由现金流经营现金流 - 资本支出 | $187.3M | $27.6M |
| 自由现金流率自由现金流/营收 | 17.9% | 290.5% |
| 资本支出强度资本支出/营收 | 3.4% | 13.2% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | $490.8M | — |
8季度趋势,按日历期对齐
经营现金流
ALGN
CLLS
| Q4 25 | $223.2M | — | ||
| Q3 25 | $188.7M | — | ||
| Q2 25 | $128.7M | — | ||
| Q1 25 | $52.7M | — | ||
| Q4 24 | $286.1M | — | ||
| Q3 24 | $263.7M | — | ||
| Q2 24 | $159.8M | $28.9M | ||
| Q1 24 | $28.7M | — |
自由现金流
ALGN
CLLS
| Q4 25 | $187.3M | — | ||
| Q3 25 | $169.0M | — | ||
| Q2 25 | $107.2M | — | ||
| Q1 25 | $27.4M | — | ||
| Q4 24 | $263.1M | — | ||
| Q3 24 | $233.9M | — | ||
| Q2 24 | $106.4M | $27.6M | ||
| Q1 24 | $19.3M | — |
自由现金流率
ALGN
CLLS
| Q4 25 | 17.9% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 10.3% | 290.5% | ||
| Q1 24 | 1.9% | — |
资本支出强度
ALGN
CLLS
| Q4 25 | 3.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 5.2% | 13.2% | ||
| Q1 24 | 0.9% | — |
现金转化率
ALGN
CLLS
| Q4 25 | 1.64× | — | ||
| Q3 25 | 3.33× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 0.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图